Restricting salt intake is considered a key component of heart failure treatment, but restricting it too much may actually worsen the outcomes for people with a common form of the condition, suggests research published online ...
Jul 18, 2022
0
75
(Medical Xpress) -- A commonly prescribed medicine used to treat conditions such as heart failure and hypertension does not present women over 55 with any increased risk of breast cancer, a new study at the University of ...
Jul 23, 2012
0
1
A medication for heart problems and high blood pressure may also be effective for treating alcohol use disorder, according to a new study by researchers at the National Institutes of Health and their colleagues. The study ...
Sep 19, 2022
0
60
Spironolactone use is not associated with an increased risk for cancer, according to a systematic review and meta-analysis published online Feb. 9 in JAMA Dermatology.
Feb 23, 2022
0
15
Higher doses of spironolactone, a diuretic (water pill), can prevent the need for dialysis in selected heart failure patients, a UT Health San Antonio study found. The aggressive approach relieved fluid overload safely and ...
Aug 2, 2019
0
90
Whenever we have to acquire new knowledge under stress, the brain deploys unconscious rather than conscious learning processes. Neuroscientists at the Ruhr-Universität Bochum have discovered that this switch from conscious ...
Jul 30, 2013
0
0
In a finding that suggests the potential for practice change that would reduce the use of antibiotics in dermatology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found the diuretic ...
Jun 4, 2018
0
4
A new study by researchers at Brigham and Women's Hospital (BWH) has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care ...
Mar 22, 2015
0
31
Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy ...
Feb 20, 2014
0
0
(HealthDay)—In a head-to-head study of mineralocorticoid receptor antagonists, spironolactone was found to be noninferior to eplerenone for slowing the progression of heart damage in boys with Duchenne muscular dystrophy ...
Oct 28, 2019
0
5
